Phoenix Holdings Ltd. Halozyme Therapeutics, Inc. Transaction History

Phoenix Holdings Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$31.82 - $40.75 $838,838 - $1.07 Million	-26,362 Closed	0 $0
Q3 2021 Oct 27, 2021	SELL	$38.47 - $46.42 $370,773 - $447,395	-9,638 Reduced 26.77%	26,362 $1.04 Million
Q2 2021 Aug 10, 2021	BUY	$38.84 - $51.31 $1.4 Million - $1.85 Million	36,000 New	36,000 $1.65 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.